Likewise, EVs derived from MSC with a small interfering RNA induced knockdown of VEGF render diminished therapeutic effects in BPD rats as compared to EVs derived from control MSC, suggesting that part of the therapeutic effects of MSC and their EVs is mediated via VEGF-dependent pathways [38]. The gene discussed is VEGFA; the disease is bronchopulmonary dysplasia.